Esperion Therapeutics
ESPR
ESPR
182 hedge funds and large institutions have $1.64B invested in Esperion Therapeutics in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 66 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more funds holding
Funds holding: 165 → 182 (+17)
7.37% more ownership
Funds ownership: 108.38% → 115.76% (+7.4%)
Holders
182
Holding in Top 10
4
Calls
$47.6M
Puts
$35.5M
Top Buyers
| 1 | +$32.9M | |
| 2 | +$22.8M | |
| 3 | +$18.2M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$17.3M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$13.6M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$8.61M | |
| 3 | -$8.46M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.08M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.59M |